Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

Given this outlook, focusing on high-yield dividend stocks and cautious valuation is essential for long-term investment ...

Organon shares have stabilized in recent times, with gradual debt reduction and structural growth allowing for a valuation re ...

NBC journalist Kristen Welker has been grabbing the limelight amidst the upcoming presidential election. While fans are aware ...

Few companies have attracted more attention this year than Nvidia. The chipmaker is on a roll thanks to the rapid rise of ...

Meniscus Tear Clinical Trial Progression: The market is poised for substantial growth, fueled by the anticipated launch of ...

Moderna stock was slumping Thursday after it announced a major pullback in its research and development efforts, as the ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S.Food and Drug Administration (FDA) ...

Ethereum, or 1 ETH, traded at $2,636.77 as of 8 a.m. ET. The highest intraday price the cryptocurrency reached in the past ...

Ethereum, or 1 ETH, traded at $2,644.63 as of 8 a.m. ET. The highest intraday price the cryptocurrency reached in the past ...

Factors related to sex and gender can affect therapy outcomes and should not be overlooked in clinical practice or research.